c-MET 抗体
MET 适用: 人, 小鼠 WB, ELISA, IHC (p), FACS, IF (cc), IF (p), IHC (fro) 宿主: 兔 Polyclonal unconjugated
MET 适用: 人, 猴 WB, ELISA, IHC, FACS, ICC 宿主: 小鼠 Monoclonal 5E9C4 unconjugated
MET 适用: 人 WB, IHC, ICC, IP 宿主: 兔 Polyclonal unconjugated
c-MET 抗体 by Grade
Find c-MET 抗体 with a specific Grade. The Grade listed below are among those available. Click on a link to go to the corresponding products.
c-MET 抗体 by 抗体来源
Find c-MET 抗体 with a specific 抗体来源. The 抗体来源 listed below are among those available. Click on a link to go to the corresponding products.
c-MET 抗体 by 克隆形成能力
Find available monoclonal or polyclonal c-MET 抗体. Click on a link to go to the corresponding products.
Popular c-MET 抗体
- (5)
- (5)
- (7)
- (5)
- (5)
- (5)
- (5)
- (4)
- (3)
- (3)
- (3)
- (3)
- (3)
- (3)
- (2)
- (2)
Latest Publications for our c-MET 抗体
: "Pharmacological induction of selective endoplasmic reticulum retention as a strategy for cancer therapy." in: Nature communications, Vol. 11, Issue 1, pp. 1304, (2020) (PubMed).: "The unfolded protein response modulators GSK2606414 and KIRA6 are potent KIT inhibitors." in: Cell death & disease, Vol. 10, Issue 4, pp. 300, (2020) (PubMed).
: "Mutant p53s generate pro-invasive niches by influencing exosome podocalyxin levels. ..." in: Nature communications, Vol. 9, Issue 1, pp. 5069, (2019) (PubMed).
: "Ezrin Promotes Stem Cell Properties in Pancreatic Ductal Adenocarcinoma." in: Molecular cancer research : MCR, Vol. 17, Issue 4, pp. 929-936, (2019) (PubMed).
: "A reference collection of patient-derived cell line and xenograft models of proneural, classical and mesenchymal glioblastoma." in: Scientific reports, Vol. 9, Issue 1, pp. 4902, (2019) (PubMed).
: "Broad-spectrum receptor tyrosine kinase inhibitors overcome de novo and acquired modes of resistance to EGFR-targeted therapies in colorectal cancer." in: Oncotarget, Vol. 10, Issue 13, pp. 1320-1333, (2019) (PubMed).
: "Induction of MET Receptor Tyrosine Kinase Down-regulation through Antibody-mediated Receptor Clustering." in: Scientific reports, Vol. 9, Issue 1, pp. 1988, (2019) (PubMed).
: "Combination therapy with c-met inhibitor and TRAIL enhances apoptosis in dedifferentiated liposarcoma patient-derived cells." in: BMC cancer, Vol. 19, Issue 1, pp. 496, (2019) (PubMed).
: "Hepatocyte growth factor (HGF) optimizes oral traumatic ulcer healing of mice by reducing inflammation." in: Cytokine, Vol. 99, pp. 275-280, (2018) (PubMed).
: "Premyogenic progenitors derived from human pluripotent stem cells expand in floating culture and differentiate into transplantable myogenic progenitors." in: Scientific reports, Vol. 8, Issue 1, pp. 6555, (2018) (PubMed).
Aliases for c-MET 抗体
MET proto-oncogene, receptor tyrosine kinase (MET) 抗体met proto-oncogene (Met) 抗体
MET proto-oncogene, receptor tyrosine kinase (Met) 抗体
MET proto-oncogene, receptor tyrosine kinase L homeolog (met.L) 抗体
AI838057 抗体
AUTS9 抗体
c-Met 抗体
c-met 抗体
C-MET 抗体
HGF 抗体
HGFR 抗体
Hgfr 抗体
MET 抗体
met 抗体
met-A 抗体
Par4 抗体
RCCP2 抗体
您还需要查找其他产品吗?
- C-JUN 抗体
- c-FOS 抗体
- BZW2 抗体
- BZW1 抗体
- Bystin-Like 抗体
- Butyrylcholinesterase 抗体
- BUD31 抗体
- BUB3 抗体
- BUB1B 抗体
- BUB1 抗体
- BTRC 抗体
- BTNL9 抗体
- BTNL3 抗体
- BTNL2 抗体
- BTN3A3 抗体
- BTN3A2 抗体
- BTN3A1 抗体
- BTN2A2 抗体
- BTN2A1 抗体
- BTN1A1 抗体
- C-Peptide 抗体
- C-Raf Proto-Oncogene Serine/Threonine Protein Kinase 抗体
- c-Rel 抗体
- C-Type Lectin Domain Family 1, Member B 抗体
- C-Type Lectin Domain Family 4, Member M 抗体
- C-Type Lectin Domain Family 6, Member A 抗体
- C10orf10 抗体
- C10orf2 抗体
- C10orf27 抗体
- C10ORF90 抗体
- C10ORF96 抗体
- C11orf46 抗体
- C11orf54 抗体
- C11orf68 抗体
- C11orf73 抗体
- C11ORF74 抗体
- C11orf82 抗体
- C12orf11 抗体
- C12orf53 抗体
- C12orf65 抗体